Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, Phase 3 study - Seino, Y; Sasaki, T; Fukatsu, A (Curr Med Res Opin, 2014)